Advertisement
A major update of the United States' system for approving medical devices was announced yesterday by the Food and Drug Administration.

FDA to Update Medical Device Approvals Process

0
Revised process will ensure new medical devices meet safety and effectiveness standards
From 2018 to 2030

Insulin Needed for T2DM Tx Set to Increase >20 Percent by 2030

0
Using higher HbA1c target in over-75s could increase disability-adjusted life-years by 44.2 percent
Millions of workers gained insurance coverage under the Affordable Care Act without adverse effects on labor markets

ACA Coverage Substantial, but Did Not Impact Labor Markets

0
Coverage gains did not negatively impact employment levels, hours worked, earnings
For patients with diabetes

Switching to High-Deductible Insurance Delays Diabetes Care

0
Delays in seeking care for first major symptom of macrovascular disease, first major diagnostic test
Diabetes outcomes do not differ for patients treated with a primary care provider who is either a physician

NPs and PAs Can Effectively Manage Diabetes in Primary Care

0
No difference in HbA1c, SBP, LDL-C with doctor, nurse practitioner, physician assistant
Adverse events for immune checkpoint inhibitors used to treat non-small cell lung cancer may be more common in real-world settings than reported in the clinical trials that led to U.S. Food and Drug Administration approvals

Immunotherapy Side Effects May Be More Common Than Thought

0
Higher rates of adverse events observed for immune checkpoint inhibitors in real-world settings
The ultrasound appearance of an echogenic deltoid muscle may predict diabetes and prediabetes

RSNA: Ultrasound of Shoulder Muscle May Help Diagnose T2DM

0
Echogenic-appearing deltoid muscle appears to be a powerful predictor of diabetic status
Use of sodium glucose cotransporter 2 inhibitors is associated with an increased risk for lower-limb amputation and diabetic ketoacidosis compared with use of glucagon-like peptide 1 receptor agonists

Higher Risk for Amputation, DKA With SGLT2 Inhibitors for T2DM

0
Risk increased for lower-limb amputation, diabetic ketoacidosis compared with GLP1 receptor agonists
In the first six months of 2018

CDC: 8.8 Percent Uninsured in U.S. in First Half of 2018

0
12.5 percent of adults aged 18-64 years and 4.4 percent of children aged 0-17 years uninsured
Coverage for adult obesity care improved substantially in Medicaid and state employee insurance programs between 2009 and 2017

Insurance Coverage for Adult Obesity Care Increasing

0
Findings among Medicaid, state employee health insurance programs in 2009 to 2017